M&A Deal Summary

AngioDynamics Acquires Navilyst Medical

On January 31, 2012, AngioDynamics acquired healthcare services company Navilyst Medical from Avista Capital Partners for 372M USD

Acquisition Highlights
  • This is AngioDynamics’ 1st transaction in the Healthcare Services sector.
  • This is AngioDynamics’ largest (disclosed) transaction.
  • This is AngioDynamics’ 5th transaction in the United States.

M&A Deal Summary
Date 2012-01-31
Target Navilyst Medical
Sector Healthcare Services
Buyer(s) AngioDynamics
Sellers(s) Avista Capital Partners
Deal Type Add-on Acquisition
Deal Value 372M USD

Target

Navilyst Medical

Marlborough, United States
Navilyst Medical, Inc. is a provider of innovative solutions for image-guided interventions delivering superior outcomes and reducing healthcare costs for medical professionals and their patients.

Search 196,284 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

AngioDynamics

Latham, New York, United States
Category Company
Founded 1988
Sector Medical Products
Employees760
Revenue 339M USD (2023)
DESCRIPTION

AngioDynamics is a provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics was incorporated in 1988 and is based in Latham, New York.

DEAL STATS #
Overall 5 of 9
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 4 of 8
Country (United States) 5 of 8
Year (2012) 1 of 2
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-12 FlowMedica

Fremont, California, United States

FlowMedica, Inc. manufactures intravascular systems for implementing Targeted Renal Therapy.

Buy $2M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-08 Vortex Medical

Norwell, Massachusetts, United States

Vortex Medical, Inc. is a medical device company focused on the design, development and commercialization of novel endomechanical devices for the endovascular market.

Buy -

Seller(S) 1

SELLER

Avista Capital Partners

New York, New York, United States
Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

DEAL STATS #
Overall 9 of 30
Sector (Healthcare Services) 2 of 3
Type (Add-on Acquisition) 5 of 15
Country (United States) 7 of 24
Year (2012) 2 of 4
Size (of disclosed) 8 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-01-31 BioReliance

Rockville, Maryland, United States

BioReliance provides critical services that include biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics, and other life science customers worldwide.

Sell $350M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-05-02 Fougera Pharmaceuticals

Melville, New York, United States

Fougera Pharmaceuticals Inc. operates two primary divisions in the US focused on specialty pharmaceuticals in dermatology: Fougera, its generic dermatology medicines business, and PharmaDerm, its branded dermatology business. Founded in 1849, the Fougera division is the leading manufacturer and distributor of a wide range of topical products. The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body.

Sell $1.5B
Mergr

Product

Company

Legal